MedTrace Logo

BST-DERMON Versus Standard of Care in the Treatment of Diabetic Foot Ulcers

NCT00434538 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2009-02-05

No results posted yet for this study

Summary

This trial is designed to investigate the therapeutic benefits of using BST-DermOn for the wound repair of diabetic neuropathic foot ulcers.

The objective of this study is to evaluate the safety and efficacy of BST-DermOn in providing a clinically significant advantage over the standard of care in the repair of diabetic foot ulcers.

Conditions

  • Diabetic Foot Ulcer

Interventions

DEVICE

BST-DermOn

Sponsors & Collaborators

  • BioSyntech Canada Inc.

    lead INDUSTRY

Principal Investigators

  • Alberto Restrepo, M.D. · Medical Monitor, BioSyntech Canada Inc

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-28
Primary Completion
2008-11-30
Completion
2008-11-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00434538 on ClinicalTrials.gov